Myelodysplastic syndrome from theoretical review to clinical application view

DOI: 10.4081/oncol.2018.397

Keywords: Myelodysplastic syndrome, lenalidomide, hypomethyating agents

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text